The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Acquired factor VIII inhibitors
Abstract
Acquired hemophilia A is a rare bleeding diathesis caused by autoantibodies directed against clotting factor VIII and associated with an increased morbidity and mortality. This autoimmune disorder most commonly occurs in the elderly. Although it may be associated with several underlying pathologies, up to 50% of reported cases remain idiopathic. In contrast with congenital hemophilia, which is commonly characterized by hemarthroses, hemorrhages in patients with acquired hemophilia involve most frequently soft tissues. The 2 treatment priorities are to arrest the acute bleeding and to eradicate the factor VIII autoantibody. Acute bleeding episodes in patients with low-titer inhibitors can be treated using human factor VIII concentrates, whereas factor VIII bypassing agents, such as activated prothrombin complex concentrates or recombinant activated factor VII, are effective for the treatment of those with high-titer inhibitors. An analysis of the literature shows that the most effective first-line treatment for the eradication of factor VIII autoantibodies is the combination of steroids and cyclophosphamide. However, there is increasing evidence on the effectiveness of other treatment approaches, such as immune tolerance regimens and rituximab. If confirmed by large controlled studies, these innovative therapies might become a valid option for long-term eradication of factor VIII inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Survey of 215 Non-Hemophilic Patients with Inhibitors to Factor VIII
Green, D., & Lechner, K. (1981) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650169 · Cited by 773
Collins, P. W., Hirsch, S., Baglin, T. P., Dolan, G., Hanley, J., Makris, M., Keeling, D. M., Liesner, R., Brown, S. A., Hay, C. R. M., et al. (2007) · Blood · doi:10.1182/blood-2006-06-029850 · Cited by 749
Acquired Haemophilia: Review and Meta‐Analysis Focused on Therapy and Prognostic Factors
Delgado, J., Jimenez‐Yuste, V., Hernandez‐Navarro, F., & Villar, A. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04162.x · Cited by 469
International recommendations on the diagnosis and treatment of patients with acquired hemophilia A
Huth-Kuhne, A., Baudo, F., Collins, P., Ingerslev, J., Kessler, C. M., Levesque, H., Castellano, M. E. M., Shima, M., & St-Louis, J. (2009) · Haematologica · doi:10.3324/haematol.2008.001743 · Cited by 433
The Treatment of Bleeding in Acquired Haemophilia with Recombinant Factor VIIa: A Multicentre Study
Hay, C. R. M., Negrier, C., & Ludlam, C. A. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1665434 · Cited by 344
Hay, C. R. M., Brown, S., Collins, P. W., Keeling, D. M., & Liesner, R. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06087.x · Cited by 327
Abshire, T., & Kenet, G. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00759.x · Cited by 314
An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab
Boye, J., Elter, T., & Engert, A. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg175 · Cited by 294
Circulating anticoagulants: a study of 40 cases and a review of the literature.
Margolius, A., Jackson, D. P., & Ratnoff, O. D. (1961) · PubMed · Cited by 278
The use of recombinant factor VIIa in the treatment of bleeding disorders
Roberts, H. R., Monroe, D. M., & White, G. C. (2004) · Blood · doi:10.1182/blood-2004-06-2223 · Cited by 275
Cited by
International recommendations on the diagnosis and treatment of patients with acquired hemophilia A
Huth-Kuhne, A., Baudo, F., Collins, P., Ingerslev, J., Kessler, C. M., Levesque, H., Castellano, M. E. M., Shima, M., & St-Louis, J. (2009) · Haematologica · doi:10.3324/haematol.2008.001743 · Cited by 433
Baudo, F., Collins, P., Huth-Kühne, A., Lévesque, H., Marco, P., Nemes, L., Pellegrini, F., Tengborn, L., & Knoebl, P. (2012) · Blood · doi:10.1182/blood-2012-02-408930 · Cited by 386
Diagnosis and management of acquired coagulation inhibitors: a guideline from UKHCDO
W Collins, P., Chalmers, E., Hart, D., Jennings, I., Liesner, R., Rangarajan, S., Talks, K., Williams, M., & R. M. Hay, C. (2013) · British Journal of Haematology · doi:10.1111/bjh.12463 · Cited by 159
Metadata
- Authors
- Franchini, M., & Lippi, G.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2008-07-15
- Volume
- 112
- Issue
- 2
- Pages
- 250-255
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2021075966
- Cited by
- 267
- References
- 46
- FWCI
- 13.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Acquired factor VIII inhibitors. https://app.cochat.ai/papers/10.1182/blood-2008-03-143586
- The paper
- Franchini, M., & Lippi, G. (2008). Acquired factor VIII inhibitors. Blood. https://doi.org/10.1182/blood-2008-03-143586
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.